These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 2972897

  • 1. New natural oestradiol/cyproterone acetate oral contraceptive for pre-menopausal women.
    Hirvonen E, Stenman UH, Mälkönen M, Rasi V, Vartiainen E, Ylöstalo P.
    Maturitas; 1988 Oct; 10(3):201-13. PubMed ID: 2972897
    [Abstract] [Full Text] [Related]

  • 2. A comparative randomized trial on the impact of two low-dose oral contraceptives on ovarian activity, cervical permeability, and endometrial receptivity.
    Rossmanith WG, Steffens D, Schramm G.
    Contraception; 1997 Jul; 56(1):23-30. PubMed ID: 9306028
    [Abstract] [Full Text] [Related]

  • 3. A regimen of oral contraceptives restricted to the periovulatory period may permit folliculogenesis but inhibit ovulation.
    Letterie GS.
    Contraception; 1998 Jan; 57(1):39-44. PubMed ID: 9554249
    [Abstract] [Full Text] [Related]

  • 4. Long-term treatment with the combination ethinylestradiol and cyproterone acetate in polycystic ovary syndrome.
    Falsetti L, Galbignani E.
    Contraception; 1990 Dec; 42(6):611-9. PubMed ID: 2150631
    [Abstract] [Full Text] [Related]

  • 5. Omitting the first oral contraceptive pills of the cycle does not automatically lead to ovulation.
    Elomaa K, Rolland R, Brosens I, Moorrees M, Deprest J, Tuominen J, Lähteenmäki P.
    Am J Obstet Gynecol; 1998 Jul; 179(1):41-6. PubMed ID: 9704763
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A, Faure N, Labrie F, Fazekas AT.
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [Abstract] [Full Text] [Related]

  • 7. Interference with ovulation by sequential treatment with the antiprogesterone RU486 and synthetic progestin.
    Kekkonen R, Alfthan H, Haukkamaa M, Heikinheimo O, Luukkainen T, Lähteenmäki P.
    Fertil Steril; 1990 Apr; 53(4):747-50. PubMed ID: 2108063
    [Abstract] [Full Text] [Related]

  • 8. Sequential regimen of the antiprogesterone RU486 and synthetic progestin for contraception.
    Kekkonen R, Lähteenmäki P, Luukkainen T, Tuominen J.
    Fertil Steril; 1993 Oct; 60(4):610-5. PubMed ID: 8405512
    [Abstract] [Full Text] [Related]

  • 9. Effects of different doses of norethisterone on ovarian function, serum sex hormone binding globulin and high density lipoprotein-cholesterol.
    Song S, Chen JK, Lu CH, Yang PJ, Yang QY, Fan BC, He ML, Gui YL, Li LM, Fotherby K.
    Contraception; 1993 Jun; 47(6):527-37. PubMed ID: 8334889
    [Abstract] [Full Text] [Related]

  • 10. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M, Carlström K.
    Acta Obstet Gynecol Scand; 1977 Jun; 56(4):351-61. PubMed ID: 602703
    [Abstract] [Full Text] [Related]

  • 11. Serum levels of d-norgestrel, luteinizing hormone, follicle-stimulating hormone, estradiol, and progesterone in women during and following ingestion of combination oral contraceptives containing dl-norgestrel.
    Brenner PF, Mishell DR, Stanczyk FZ, Goebelsmann U.
    Am J Obstet Gynecol; 1977 Sep 15; 129(2):133-40. PubMed ID: 900174
    [Abstract] [Full Text] [Related]

  • 12. Oral contraceptive containing natural estradiol for premenopausal women.
    Hirvonen E, Allonen H, Anttila M, Kulmala Y, Ranta T, Rautiainen H, Sipilä P, Ylöstalo P.
    Maturitas; 1995 Jan 15; 21(1):27-32. PubMed ID: 7731379
    [Abstract] [Full Text] [Related]

  • 13. Effect of short-term cyclic administration of cyproterone acetate on pituitary-ovarian function in the human.
    Kumari GI, Das RP, Madoiya KK, Jain AK, Roy S.
    Fertil Steril; 1977 Nov 15; 28(11):1168-74. PubMed ID: 562781
    [Abstract] [Full Text] [Related]

  • 14. Metabolic changes during treatment with two different progestogens.
    Refn H, Kjaer A, Lebech AM, Borggaard B, Schierup L, Bremmelgaard A.
    Am J Obstet Gynecol; 1990 Jul 15; 163(1 Pt 2):374-7. PubMed ID: 2115298
    [Abstract] [Full Text] [Related]

  • 15. Serum levels of FSH, LH, estradiol-17 beta and progesterone following the administration of a combined oral contraceptive containing 20 micrograms ethinylestradiol.
    Carlström K, Lunell NO, Zador G.
    Gynecol Obstet Invest; 1978 Jul 15; 9(6):304-11. PubMed ID: 754992
    [Abstract] [Full Text] [Related]

  • 16. Effects of intermittent antiprogestin RU486 combined with cyclic medroxyprogesterone acetate on folliculogenesis and ovulation.
    Kekkonen R, Croxatto HB, Lähteenmäki P, Salvatierra AM, Tuominen J.
    Hum Reprod; 1995 Feb 15; 10(2):287-92. PubMed ID: 7769050
    [Abstract] [Full Text] [Related]

  • 17. Suppression of ovarian function with the transdermally given synthetic progestin ST 1435.
    Laurikka-Routti M, Haukkamaa M, Lähteenmäki P.
    Fertil Steril; 1992 Oct 15; 58(4):680-4. PubMed ID: 1426309
    [Abstract] [Full Text] [Related]

  • 18. Long-term treatment of hirsutism: desogestrel compared with cyproterone acetate in oral contraceptives.
    Porcile A, Gallardo E.
    Fertil Steril; 1991 May 15; 55(5):877-81. PubMed ID: 1827074
    [Abstract] [Full Text] [Related]

  • 19. Ovulatory dysfunction during continuous administration of low-dose levonorgestrel by subdermal implants.
    Faundes A, Brache V, Tejada AS, Cochon L, Alvarez-Sanchez F.
    Fertil Steril; 1991 Jul 15; 56(1):27-31. PubMed ID: 1906017
    [Abstract] [Full Text] [Related]

  • 20. Modulation of ovarian function by an oral contraceptive containing 30 micrograms ethinyl estradiol in combination with 2.00 mg dienogest.
    Spona J, Feichtinger W, Kindermann C, Moore C, Mellinger U, Walter F, Gräser T.
    Contraception; 1997 Sep 15; 56(3):185-91. PubMed ID: 9347211
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.